Regulation of LncRNAs and MicroRNAs in Neuronal Development and Disease

Overview

Journal PeerJ

Specialties Biology
Environmental Health
General Medicine

Date 2023 Apr 11

PMID 37038472

Authors

Cheng Xuan

Enyu Yang

Shuo Zhao

Juan Xu

PeiHang Li

Yaping Zhang

Zhenggang Jiang

Xianfeng Ding

Affiliations

Soon will be listed here.

Abstract

Non-coding RNAs (ncRNAs) are RNAs that do not encode proteins but play important roles in regulating cellular processes. Multiple studies over the past decade have demonstrated the role of microRNAs (miRNAs) in cancer, in which some miRNAs can act as biomarkers or provide therapy target. Accumulating evidence also points to the importance of long non-coding RNAs (lncRNAs) in regulating miRNA-mRNA networks. An increasing number of ncRNAs have been shown to be involved in the regulation of cellular processes, and dysregulation of ncRNAs often heralds disease. As the population ages, the incidence of neurodegenerative diseases is increasing, placing enormous pressure on global health systems. Given the excellent performance of ncRNAs in early cancer screening and treatment, here we attempted to aggregate and analyze the regulatory functions of ncRNAs in neuronal development and disease. In this review, we summarize current knowledge on ncRNA taxonomy, biogenesis, and function, and discuss current research progress on ncRNAs in relation to neuronal development, differentiation, and neurodegenerative diseases.

Citing Articles

lncRNA PART1 improves sevoflurane-induced impairments in learning and cognitive function by regulating miR-16-5p expression and reducing neuroinflammation.

Lin Y, Yu W, Yang W, Wang N, Zhang Q, Guan Y Toxicol Res (Camb). 2025; 14(1):tfaf009.

PMID: 39872305 PMC: 11766745. DOI: 10.1093/toxres/tfaf009.

Recent Advances in the miRNA-Mediated Regulation of Neuronal Differentiation and Death.

Patranabis S Neuromolecular Med. 2024; 26(1):52.

PMID: 39648193 DOI: 10.1007/s12017-024-08820-2.

Neuroprotection and Mechanism of Gas-miR36-5p from in an Alzheimer's Disease Model by Regulating Glycogen Synthase Kinase-3β.

Lu Z, Fu J, Wu G, Yang Z, Wu X, Wang D Int J Mol Sci. 2023; 24(24).

PMID: 38139125 PMC: 10744203. DOI: 10.3390/ijms242417295.

References

Zalfa F, Adinolfi S, Napoli I, Kuhn-Holsken E, Urlaub H, Achsel T . Fragile X mental retardation protein (FMRP) binds specifically to the brain cytoplasmic RNAs BC1/BC200 via a novel RNA-binding motif. J Biol Chem. 2005; 280(39):33403-10. DOI: 10.1074/jbc.M504286200. View

Pobezinsky L, Wells A . Let's fight cancer: let-7 is a tool to enhance antitumor immune responses. Future Oncol. 2018; 14(12):1141-1145. DOI: 10.2217/fon-2018-0037. View

Ma Q, Galasko D, Ringman J, Vinters H, Edland S, Pomakian J . Reduction of SorLA/LR11, a sorting protein limiting beta-amyloid production, in Alzheimer disease cerebrospinal fluid. Arch Neurol. 2009; 66(4):448-57. PMC: 2742778. DOI: 10.1001/archneurol.2009.22. View

Arisi I, DOnofrio M, Brandi R, Felsani A, Capsoni S, Drovandi G . Gene expression biomarkers in the brain of a mouse model for Alzheimer's disease: mining of microarray data by logic classification and feature selection. J Alzheimers Dis. 2011; 24(4):721-38. DOI: 10.3233/JAD-2011-101881. View

Johnstone K, Dubose A, Futtner C, Elmore M, Brannan C, Resnick J . A human imprinting centre demonstrates conserved acquisition but diverged maintenance of imprinting in a mouse model for Angelman syndrome imprinting defects. Hum Mol Genet. 2005; 15(3):393-404. DOI: 10.1093/hmg/ddi456. View

Gong L, Xu H, Guo G, Zhang T, Shi J, Chang C . Long Non-Coding RNA H19 Protects H9c2 Cells against Hypoxia-Induced Injury by Targeting MicroRNA-139. Cell Physiol Biochem. 2017; 44(3):857-869. DOI: 10.1159/000485354. View

Konopka W, Kiryk A, Novak M, Herwerth M, Parkitna J, Wawrzyniak M . MicroRNA loss enhances learning and memory in mice. J Neurosci. 2010; 30(44):14835-42. PMC: 6633640. DOI: 10.1523/JNEUROSCI.3030-10.2010. View

Jiao S, Liu Y, Yao Y, Teng J . miR-124 promotes proliferation and neural differentiation of neural stem cells through targeting DACT1 and activating Wnt/β-catenin pathways. Mol Cell Biochem. 2018; 449(1-2):305-314. DOI: 10.1007/s11010-018-3367-z. View

Carrieri C, Forrest A, Santoro C, Persichetti F, Carninci P, Zucchelli S . Expression analysis of the long non-coding RNA antisense to Uchl1 (AS Uchl1) during dopaminergic cells' differentiation in vitro and in neurochemical models of Parkinson's disease. Front Cell Neurosci. 2015; 9:114. PMC: 4381646. DOI: 10.3389/fncel.2015.00114. View

10.

Jauhari A, Singh T, Yadav S . Expression of miR-145 and Its Target Proteins Are Regulated by miR-29b in Differentiated Neurons. Mol Neurobiol. 2018; 55(12):8978-8990. DOI: 10.1007/s12035-018-1009-9. View

11.

Maldonado-Lasuncion I, Atienza M, Sanchez-Espinosa M, Cantero J . Aging-Related Changes in Cognition and Cortical Integrity are Associated With Serum Expression of Candidate MicroRNAs for Alzheimer Disease. Cereb Cortex. 2018; 29(10):4426-4437. DOI: 10.1093/cercor/bhy323. View

12.

Wevrick R, Francke U . An imprinted mouse transcript homologous to the human imprinted in Prader-Willi syndrome (IPW) gene. Hum Mol Genet. 1997; 6(2):325-32. DOI: 10.1093/hmg/6.2.325. View

13.

Mus E, Hof P, Tiedge H . Dendritic BC200 RNA in aging and in Alzheimer's disease. Proc Natl Acad Sci U S A. 2007; 104(25):10679-84. PMC: 1965572. DOI: 10.1073/pnas.0701532104. View

14.

Gururajan A . Sex Differences in Susceptibility to Depression: A Role for LncRNAs. Neuron. 2020; 106(6):871-872. DOI: 10.1016/j.neuron.2020.05.016. View

15.

Wang B, Zhang C, Du X, Zhang J . lncRNA-disease association prediction based on latent factor model and projection. Sci Rep. 2021; 11(1):19965. PMC: 8497550. DOI: 10.1038/s41598-021-99493-5. View

16.

Roberts T, Morris K, Wood M . The role of long non-coding RNAs in neurodevelopment, brain function and neurological disease. Philos Trans R Soc Lond B Biol Sci. 2014; 369(1652). PMC: 4142028. DOI: 10.1098/rstb.2013.0507. View

17.

Packer A, Xing Y, Harper S, Jones L, Davidson B . The bifunctional microRNA miR-9/miR-9* regulates REST and CoREST and is downregulated in Huntington's disease. J Neurosci. 2009; 28(53):14341-6. PMC: 3124002. DOI: 10.1523/JNEUROSCI.2390-08.2008. View

18.

Johnson R, Buckley N . Gene dysregulation in Huntington's disease: REST, microRNAs and beyond. Neuromolecular Med. 2009; 11(3):183-99. DOI: 10.1007/s12017-009-8063-4. View

19.

Cui Y, Yin Y, Xiao Z, Zhao Y, Chen B, Yang B . LncRNA Neat1 mediates miR-124-induced activation of Wnt/β-catenin signaling in spinal cord neural progenitor cells. Stem Cell Res Ther. 2019; 10(1):400. PMC: 6921476. DOI: 10.1186/s13287-019-1487-3. View

20.

Salim S . Oxidative Stress and the Central Nervous System. J Pharmacol Exp Ther. 2016; 360(1):201-205. PMC: 5193071. DOI: 10.1124/jpet.116.237503. View